<DOC>
	<DOC>NCT02044627</DOC>
	<brief_summary>This Phase 1 study will assess the mass balance recover of carbon-14 (14C) labelled ETC-1002 and the routes and rates of excretion of [14C]-ETC-1002</brief_summary>
	<brief_title>Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Healthy Male Volunteers BMI 1035 kg/m2 Hx of CV, renal, hepatic, chronic respiratory or GI disease Hx of drug or alcohol abuse smoking within 12 mos of screening</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>